Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

From Metcalf to myeloproliferative neoplasms - a personal journey.

Experimental hematology - 1 Jan 2022

Green Tony

Abstract excerpt

The human myeloproliferative neoplasms constitute a biologically fascinating group of chronic myeloid malignancies. This perspective outlines how a postdoctoral fellowship working in Don Metcalf's unit proved a formative and immensely enjoyable experience for my family and me. It laid the foundation for a subsequent body of work over three decades that revealed the genetic basis of these diseases, defined how...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Janus Kinase 2
Share to Calreticulin
Share to Genetic Predisposition to Disease

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Hematologic Neoplasms

Share to Hematopoiesis

Share to Mutation

Share to Myeloproliferative Disorders

Share to Prognosis

Source

Identifiers

PMID: 34706253
DOI: 10.1016/j.exphem.2021.10.004

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

From Metcalf to myeloproliferative neoplasms - a personal journey.PMID 34706253Read ↗

Myeloproliferative neoplasms: from origins to outcomes.Semantic proximity Read ↗

Myeloproliferative neoplasms: from origins to outcomes.Semantic proximity Read ↗

How I diagnose and treat chronic myelomonocytic leukemia.Semantic proximity Read ↗

[Current outlook on mutations of myeloproliferative neoplasms].Semantic proximity Read ↗

[The cutting edge of medicine: pathophysiology and treatment of myeloproliferative neoplasms].Semantic proximity Read ↗

Molecular aspects of myeloproliferative neoplasmsSemantic proximity Read ↗

On the molecular origins of the chronic myeloproliferative disorders: it all makes sense.Semantic proximity Read ↗

[Molecular biology of myeloproliferative neoplasms].Semantic proximity Read ↗

[Molecular physiopathology of chronic myeloproliferative disorders].Semantic proximity Read ↗

Oncogenic Drivers in Myeloproliferative Neoplasms: From JAK2 to Calreticulin Mutations.Semantic proximity Read ↗

Oncogenes in myeloproliferative disorders.Semantic proximity Read ↗

Paving the way to improve therapy for Myeloproliferative Neoplasms.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.